SGMT — SAGIMET BIOSCIENCES INC
As of Q2 2026, 28 SEC-registered investment managers reported holding SGMT (SAGIMET BIOSCIENCES INC) in their latest 13F filings, with a combined reported value of $131.39M across 17.05M shares. That is +191.6% by share count (+11.20M shares) versus the previous quarter, while reported value moved +330.3%. Ownership is concentrated: the five largest holders account for 78.5% of reported value and the top ten for 92.0%.
Compared with the prior quarter, 10 opened new positions, 15 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SGMT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.58M | $50.83M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 3.63M | $28.03M | 0.04% | New |
| Geode Capital Management history | Q2 2026 | 1.44M | $11.17M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 1.26M | $7.46M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 937.02K | $7.24M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 759.09K | $5.87M | 0.00% | Add |
| Hillhouse Capital (HHLR Advisors) history | Q2 2026 | 724.80K | $5.60M | 0.67% | Hold |
| Marshall Wace history | Q1 2026 | 966.25K | $5.04M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 468.38K | $3.62M | 0.00% | Add |
| Farallon Capital Management history | Q2 2026 | 415.00K | $3.21M | 0.01% | New |
| Renaissance Technologies history | Q2 2026 | 346.93K | $2.68M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 339.93K | $2.63M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 289.93K | $2.24M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 200.65K | $1.55M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 175.87K | $1.36M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 143.68K | $1.11M | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 187.56K | $980.02K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 102.23K | $790.21K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 81.90K | $633.10K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 64.00K | $494.69K | 0.00% | Add |
New Positions (Q2 2026)
- Balyasny Asset Management 3.63M sh · $28.03M
- Farallon Capital Management 415.00K sh · $3.21M
- BNY Mellon 200.65K sh · $1.55M
- Deutsche Bank AG 58.20K sh · $449.90K
- Wellington Management Group 40.80K sh · $315.38K
- Invesco Ltd 34.73K sh · $268.47K
- JPMorgan Chase & Co 28.93K sh · $225.36K
- Manulife Financial 15.31K sh · $118.33K
- Legal & General Investment Management America 5.70K sh · $44.05K
- T. Rowe Price Associates 48.88K sh · $378
Fully Exited (vs previous quarter)
- Marshall Wace sold 966.25K sh · $5.04M
- Point72 Asset Management sold 187.56K sh · $980.02K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | 952.59K | 978.72K | 970.82K | 483.08K | 612.72K | 813.95K | 799.94K | 6.58M |
| Balyasny Asset Management | — | — | — | — | — | — | 242.84K | — | — | — | — | 3.63M |
| Geode Capital Management | 110.70K | 120.78K | 399.80K | 161.05K | 252.30K | 255.24K | 263.72K | 265.32K | 283.21K | 295.86K | 309.52K | 1.44M |
| Millennium Management | 12.23K | 48.05K | 620.43K | 576.75K | 194.15K | 693.25K | 160.91K | 163.44K | 776.38K | 586.95K | 862.30K | 937.02K |
| Goldman Sachs Group | 19.65K | — | 29.75K | 262.09K | 132.72K | 133.07K | 23.60K | 18.62K | 15.19K | 125.95K | 169.26K | 759.09K |
| Hillhouse Capital (HHLR Advisors) | 1.45M | 1.45M | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K | 724.80K |
| Northern Trust Corp | 41.93K | 46.82K | 168.25K | 149.98K | 40.86K | 40.86K | 52.30K | 52.30K | 52.30K | 55.51K | 55.51K | 468.38K |
| Farallon Capital Management | — | — | — | — | — | — | — | — | — | — | — | 415.00K |
| Renaissance Technologies | — | 23.00K | 419.40K | 242.40K | 231.10K | 10.80K | — | 30.90K | 161.40K | 342.50K | 625.47K | 346.93K |
| UBS Group AG | 2.99K | 19.99K | 63.14K | 96.37K | 141.26K | 333.16K | 478.43K | 572.74K | 306.77K | 201.76K | 293.93K | 339.93K |
| Citadel Advisors | 311.63K | — | 30.27K | 1.20M | 1.28M | 824.33K | 119.47K | 258.18K | 166.44K | 223.82K | 210.77K | 289.93K |
| BNY Mellon | 13.30K | 22.12K | 62.18K | — | — | — | — | — | — | — | — | 200.65K |
| Charles Schwab Investment Management | 12.56K | 12.56K | 51.87K | — | — | — | 15.00K | 15.00K | 15.00K | 15.00K | 15.00K | 175.87K |
| Bank of America Corp | 12.99K | 16.68K | 257.22K | 495.03K | 540.44K | 15.04K | 5.47K | 9.94K | 25.71K | 9.88K | 43.86K | 143.68K |
| Morgan Stanley | 17.46K | 11.91K | 81.22K | 339.19K | 271.43K | 278.19K | 276.05K | 195.49K | 246.08K | 89.24K | 93.31K | 102.23K |
| Two Sigma Investments | — | 43.90K | 75.22K | 73.98K | 183.64K | 50.43K | 49.85K | 13.04K | 51.19K | 42.53K | 40.13K | 81.90K |
| Wells Fargo & Co | 1.22K | 1.59K | 7.52K | — | — | 6.81K | 17.50K | 6.50K | 7.00K | 8.00K | 9.27K | 64.00K |
| Deutsche Bank AG | — | — | 9.72K | — | — | — | — | — | — | — | — | 58.20K |
| Citigroup Inc | — | 858 | 5.01K | 135.74K | 116.73K | 111.21K | — | 3.63K | — | 17.98K | 13.59K | 52.84K |
| Wellington Management Group | — | — | — | — | — | — | — | — | — | — | — | 40.80K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details